Navigation Links
Hope For Patients With Inflammatory Bowel Disease

Researchers say they may have discovered a potential form of relief for patients with inflammatory bowel disease.//

More than 1 million Americans are estimated to have ulcerative colitis or Crohn’s disease the two major forms of inflammatory bowel disease. The conditions, can be painful and debilitating, and can cause chronic inflammation of the digestive tracts. Patients with inflammatory bowel disease suffer bouts of watery diarrhea and abdominal pain and there is no known medical cure for either ulcerative colitis or Crohn’s disease, although medications can help symptoms.

Recent research has shown that anti-inflammatory therapy has offered relief in mouse models of Crohn’s disease and ulcerative colitis hence researchers explored how an immune system molecule called Toll-like receptor 9 could ease inflammation. Agents that activate Toll-like receptor 9, or TLR9, were given to two different groups of mice that appeared similar but were from different genetic strains. Reactions were different in the two strains of mice. The TLR9 activators inhibited the severity of experimental colitis but had no effect on the other group of mice.

To understand why the mice reacted differently, researchers used a variety of approaches to explore why one strain responded to therapy, and the other was resistant. They determined the TLR9-induced protection occurs when proteins called type 1 IFN-alpha and IFN-beta were activated. Thus researchers say based on their findings type 1 IFN-alpha and IFN-beta has a very important protective and potential therapeutic role .
'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in wound care advancements to physician colleagues, skilled nursing facility medical directors and ... the Treacherous Waters of Wound Care." , "At many of these conferences we ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... -- AVACEN Medical , Inc. (AVACEN) announced that Frost ... Product Innovation Award for Its fibromyalgia pain management device. ... device market research by Frost & Sullivan,s industry experts. ... relief product, the AVACEN 100, offers a safe and effective ... ...
(Date:10/11/2017)... Texas , Oct. 11, 2017  Caris Life ... focused on fulfilling the promise of precision medicine, today ... has joined Caris, Precision Oncology Alliance™ (POA) as its ... cancer centers, the St. Jude Crosson Cancer Institute will ... advance the use of tumor profiling, making cancer treatment ...
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
Breaking Medicine Technology: